← 返回

mtDNA-cGAS-STING 轴在肿瘤免疫中的作用:从免疫激活到免疫逃逸

英文原题:The roles of the mtDNA-cGAS-STING axis in tumor immunity: from immune activation to immune evasion.

查看英文原题

The roles of the mtDNA-cGAS-STING axis in tumor immunity: from immune activation to immune evasion.

PubMed 2026/01/12(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

在肿瘤微环境(TME)中,应激诱导的线粒体DNA(mtDNA)泄漏激活mtDNA-环鸟苷酸-腺苷酸合成酶(cGAS)-干扰素基因刺激因子(STING)轴,在肿瘤免疫中发挥“双刃剑”作用。一方面,它通过cGAS合成环鸟苷酸-腺苷酸(cGAMP)激活STING-干扰素调节因子3(IRF3)通路,诱导I型干扰素(IFN-I),增强CD8+ T细胞和自然杀伤(NK)细胞的细胞毒性功能以及树突状细胞(DCs)的抗原提呈能力,还促进M1巨噬细胞极化和中性粒细胞胞外诱捕网(NETs)形成,从而驱动免疫激活。另一方面,该轴的持续激活可诱导程序性细胞死亡配体1(PD-L1)表达,招募髓源性抑制细胞(MDSCs),并导致T细胞耗竭,促进肿瘤免疫逃逸。靶向mtDNA稳定性、构建纳米药物递送系统或联合免疫检查点阻断可重塑肿瘤免疫微环境,为精准免疫治疗提供新思路。本文系统总结了该轴对肿瘤免疫微环境的双重效应,不仅深化了对肿瘤免疫学的认识,也为精准肿瘤免疫治疗的研究、开发与优化提供指导,有望改善患者预后。

展开英文摘要原文

In the tumor microenvironment (TME), stress-induced mitochondrial DNA (mtDNA) leakage activates the mtDNA-cyclic GMP-AMP synthase (cGAS)- stimulator of interferon genes (STING) axis, which exerts a "double-edged sword" role in tumor immunity. On the one hand, it activates the STING- interferon regulatory factor 3 (IRF3) pathway via cyclic GMP-AMP (cGAMP) synthesis by cGAS, induces type I interferons (IFN-I), enhances the cytotoxic functions of CD8 + T cells and natural killer (NK) cells as well as the antigen-presenting capacity of dendritic cells (DCs), and also promotes M1 macrophage polarization and neutrophil extracellular trap (NETs) formation, thereby driving immune activation.

On the other hand, sustained activation of this axis can induce programmed cell death ligand 1 (PD-L1) expression, recruit myeloid-derived suppressor cells (MDSCs), and cause T cells exhaustion, facilitating tumor immune evasion. Targeting mtDNA stability, constructing nano-drug delivery systems, or combining with immune checkpoint blockade can reshape the tumor immune microenvironment and provide new ideas for precision immunotherapy.

This article systematically summarizes the dual effects of this axis on the tumor immune microenvironment, which not only deepens the understanding of cancer immunology but also provides guidance for the research, development, and optimization of precision tumor immunotherapies, and is expected to improve patient prognosis.

论文信息

作者
Huang N、Liu Z、Lei H、Liu X
单位
Department of Clinical Pharmacy, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), Xiangtan, China.China
文献类型
综述
期刊
Frontiers in immunology2025
原文标识
PubMed 41601699 · DOI 10.3389/fimmu.2025.1739559